Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001267602-16-000189
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-12-14 16:30:46
Reporting Period:
2016-12-12
Filing Date:
2016-12-14
Accepted Time:
2016-12-14 16:30:46
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1267602 Alimera Sciences Inc ALIM Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1489535 W. Calvin Roberts
6120 Windward Parkway, Suite 290
Alpharetta GA 30005
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2016-12-12 20,000 $1.11 75,620 No 4 S Indirect See Footnote (1)
Common Stock Disposition 2016-12-12 30,000 $1.11 65,820 No 4 S Indirect See Footnote (2)
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See Footnote (1)
No 4 S Indirect See Footnote (2)
Footnotes
  1. The shares are held by The David Roberts Trust. Calvin Roberts is a Trustee of The David Roberts Trust. Calvin Roberts disclaims beneficial ownership of these securities and this report shall not be deemed an admission that he is the beneficial owner of such securities for the purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interest therein.
  2. The shares are held by The Lindsay Roberts Trust. Calvin Roberts is a Trustee of The Lindsay Roberts Trust. Calvin Roberts disclaims beneficial ownership of these securities and this report shall not be deemed an admission that he is the beneficial owner of such securities for the purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interest therein.